{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:47:42Z","timestamp":1792604862770,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T00:00:00Z","timestamp":1460592000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1186\/s12876-016-0448-x","type":"journal-article","created":{"date-parts":[[2016,4,14]],"date-time":"2016-04-14T10:40:05Z","timestamp":1460630405000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Randomized, multicenter study: on-demand versus continuous maintenance treatment with esomeprazole in patients with non-erosive gastroesophageal reflux disease"],"prefix":"10.1186","volume":"16","author":[{"given":"Ekkehard","family":"Bayerd\u00f6rffer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc-Andre","family":"Bigard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Werner","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferm\u00edn","family":"Mearin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Rodrigo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Enrique","family":"Dominguez Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hennie","family":"Grundling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars-Erik","family":"Svedberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna","family":"Keeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Eklund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,4,14]]},"reference":[{"issue":"3","key":"448_CR1","doi-asserted-by":"publisher","first-page":"42","DOI":"10.3810\/pgm.2001.09.1017","volume":"110","author":"A Kaynard","year":"2001","unstructured":"Kaynard A, Flora K. Gastroesophageal reflux disease. Control of symptoms, prevention of complications. Postgrad Med. 2001;110(3):42\u20134. 4 7\u20138, 51\u20133.","journal-title":"Postgrad Med"},{"issue":"8","key":"448_CR2","doi-asserted-by":"publisher","first-page":"1900","DOI":"10.1111\/j.1572-0241.2006.00630.x","volume":"101","author":"N Vakil","year":"2006","unstructured":"Vakil N, van Zanten SV, Kahrilas P, Dent J, Jones R. The Montreal definition and classification of gastroesophageal reflux disease: a global evidence-based consensus. Am J Gastroenterol. 2006;101(8):1900\u201320. quiz 43.","journal-title":"Am J Gastroenterol"},{"issue":"5","key":"448_CR3","doi-asserted-by":"publisher","first-page":"1448","DOI":"10.1016\/S0016-5085(97)70025-8","volume":"112","author":"GR Locke 3rd","year":"1997","unstructured":"Locke 3rd GR, Talley NJ, Fett SL, Zinsmeister AR, Melton 3rd LJ. Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology. 1997;112(5):1448\u201356.","journal-title":"Gastroenterology"},{"issue":"1","key":"448_CR4","doi-asserted-by":"publisher","first-page":"8","DOI":"10.5056\/jnm.2010.16.1.8","volume":"16","author":"T Hershcovici","year":"2010","unstructured":"Hershcovici T, Fass R. Nonerosive Reflux Disease (NERD) - an update. J Neurogastroenterol Motil. 2010;16(1):8\u201321.","journal-title":"J Neurogastroenterol Motil"},{"issue":"7","key":"448_CR5","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1111\/j.1572-0241.1999.01206.x","volume":"94","author":"T Havelund","year":"1999","unstructured":"Havelund T, Lind T, Wiklund I, Glise H, Hernqvist H, Lauritsen K, et al. Quality of life in patients with heartburn but without esophagitis: effects of treatment with omeprazole. Am J Gastroenterol. 1999;94(7):1782\u20139.","journal-title":"Am J Gastroenterol"},{"issue":"8","key":"448_CR6","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1046\/j.1365-2036.2003.01770.x","volume":"18","author":"M Kulig","year":"2003","unstructured":"Kulig M, Leodolter A, Vieth M, Schulte E, Jaspersen D, Labenz J, et al. Quality of life in relation to symptoms in patients with gastro-oesophageal reflux disease-- an analysis based on the ProGERD initiative. Aliment Pharmacol Ther. 2003;18(8):767\u201376.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"448_CR7","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000200917","volume":"51","author":"NJ Bell","year":"1992","unstructured":"Bell NJ, Burget D, Howden CW, Wilkinson J, Hunt RH. Appropriate acid suppression for the management of gastro-oesophageal reflux disease. Digestion. 1992;51 Suppl 1:59\u201367.","journal-title":"Digestion"},{"issue":"10","key":"448_CR8","doi-asserted-by":"publisher","first-page":"974","DOI":"10.3109\/00365529709011212","volume":"32","author":"T Lind","year":"1997","unstructured":"Lind T, Havelund T, Carlsson R, Anker-Hansen O, Glise H, Hernqvist H, et al. Heartburn without oesophagitis: efficacy of omeprazole therapy and features determining therapeutic response. Scand J Gastroenterol. 1997;32(10):974\u20139.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"448_CR9","first-page":"577","volume":"7","author":"JW Freston","year":"1995","unstructured":"Freston JW, Malagelada JR, Petersen H, McCloy RF. Critical issues in the management of gastroesophageal reflux disease. Eur J Gastroenterol Hepatol. 1995;7(6):577\u201386.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"12","key":"448_CR10","doi-asserted-by":"publisher","first-page":"2616","DOI":"10.1111\/j.1572-0241.2003.08783.x","volume":"98","author":"P Miner Jr","year":"2003","unstructured":"Miner Jr P, Katz PO, Chen Y, Sostek M. Gastric acid control with esomeprazole, lansoprazole, omeprazole, pantoprazole, and rabeprazole: a five-way crossover study. Am J Gastroenterol. 2003;98(12):2616\u201320.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"448_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2165\/00044011-200424010-00001","volume":"24","author":"K R\u00f6hss","year":"2004","unstructured":"R\u00f6hss K, Wilder-Smith C, Naucl\u00e9r E, Jansson L. Esomeprazole 20\u00a0mg provides more effective intragastric acid control than maintenance-dose rabeprazole, lansoprazole or pantoprazole in healthy volunteers. Clin Drug Investig. 2004;24(1):1\u20137.","journal-title":"Clin Drug Investig"},{"issue":"3","key":"448_CR12","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1046\/j.1365-2036.2001.00943.x","volume":"15","author":"NJ Talley","year":"2001","unstructured":"Talley NJ, Lauritsen K, Tunturi-Hihnala H, Lind T, Moum B, Bang C, et al. Esomeprazole 20\u00a0mg maintains symptom control in endoscopy-negative gastro-oesophageal reflux disease: a controlled trial of \u2018on-demand\u2019 therapy for 6\u00a0months. Aliment Pharmacol Ther. 2001;15(3):347\u201354.","journal-title":"Aliment Pharmacol Ther"},{"issue":"1","key":"448_CR13","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1053\/gast.1996.v111.pm8698230","volume":"111","author":"D Armstrong","year":"1996","unstructured":"Armstrong D, Bennett JR, Blum AL, Dent J, De Dombal FT, Galmiche JP, et al. The endoscopic assessment of esophagitis: a progress report on observer agreement. Gastroenterology. 1996;111(1):85\u201392.","journal-title":"Gastroenterology"},{"issue":"10","key":"448_CR14","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.1097\/00000478-199610000-00001","volume":"20","author":"MF Dixon","year":"1996","unstructured":"Dixon MF, Genta RM, Yardley JH, Correa P. Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol. 1996;20(10):1161\u201381.","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"448_CR15","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1023\/A:1008841022998","volume":"7","author":"DA Revicki","year":"1998","unstructured":"Revicki DA, Wood M, Wiklund I, Crawley J. Reliability and validity of the Gastrointestinal Symptom Rating Scale in patients with gastroesophageal reflux disease. Qual Life Res. 1998;7(1):75\u201383.","journal-title":"Qual Life Res"},{"issue":"6","key":"448_CR16","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1023\/A:1025192100450","volume":"12","author":"KR Kulich","year":"2003","unstructured":"Kulich KR, Wiklund I, Junghard O. Factor structure of the Quality of life in reflux and dyspepsia (QOLRAD) questionnaire evaluated in patients with heartburn predominant reflux disease. Qual Life Res. 2003;12(6):699\u2013708.","journal-title":"Qual Life Res"},{"key":"448_CR17","unstructured":"Wiklund IK, Junghard O, Grace E, Talley NJ, Kamm M, Veldhuyzen van Zanten S, et al. Quality of life in reflux and dyspepsia patients. Psychometric documentation of a new disease-specific questionnaire (QOLRAD). Eur J Surg Suppl. 1998;164(583):41\u20139."},{"issue":"1","key":"448_CR18","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1007\/BF00434379","volume":"4","author":"HE Drummond","year":"1995","unstructured":"Drummond HE, Ghosh S, Ferguson A, Brackenridge D, Tiplady B. Electronic quality of life questionnaires: a comparison of pen-based electronic questionnaires with conventional paper in a gastrointestinal study. Qual Life Res. 1995;4(1):21\u20136.","journal-title":"Qual Life Res"},{"issue":"2","key":"448_CR19","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1136\/gut.45.2.172","volume":"45","author":"LR Lundell","year":"1999","unstructured":"Lundell LR, Dent J, Bennett JR, Blum AL, Armstrong D, Galmiche JP, et al. Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut. 1999;45(2):172\u201380.","journal-title":"Gut"},{"issue":"8","key":"448_CR20","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1097\/00042737-200208000-00008","volume":"14","author":"NJ Talley","year":"2002","unstructured":"Talley NJ, Venables TL, Green JR, Armstrong D, O\u2019Kane KP, Giaffer M, et al. Esomeprazole 40\u00a0mg and 20\u00a0mg is efficacious in the long-term management of patients with endoscopy-negative gastro-oesophageal reflux disease: a placebo-controlled trial of on-demand therapy for 6\u00a0months. Eur J Gastroenterol Hepatol. 2002;14(8):857\u201363.","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"7","key":"448_CR21","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/MCG.0b013e3181dd9c5b","volume":"44","author":"DA Johnson","year":"2010","unstructured":"Johnson DA, Katz PO, Levine D, R\u00f6hss K, Astrand M, Junghard O, et al. Prevention of relapse of healed reflux esophagitis is related to the duration of intragastric pH\u2009>\u20094. J Clin Gastroenterol. 2010;44(7):475\u20138.","journal-title":"J Clin Gastroenterol"},{"issue":"3","key":"448_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1046\/j.1365-2036.2003.01464.x","volume":"17","author":"K Lauritsen","year":"2003","unstructured":"Lauritsen K, Devi\u00e8re J, Bigard MA, Bayerd\u00f6rffer E, M\u00f3zsik G, Murray F, et al. Esomeprazole 20\u00a0mg and lansoprazole 15\u00a0mg in maintaining healed reflux oesophagitis: Metropole study results. Aliment Pharmacol Ther. 2003;17(3):333\u201341.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"448_CR23","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1111\/j.1365-2036.2005.02643.x","volume":"22","author":"J Labenz","year":"2005","unstructured":"Labenz J, Armstrong D, Lauritsen K, Katelaris P, Schmidt S, Sch\u00fctze K, et al. Esomeprazole 20\u00a0mg vs. pantoprazole 20\u00a0mg for maintenance therapy of healed erosive oesophagitis: results from the EXPO study. Aliment Pharmacol Ther. 2005;22(9):803\u201311.","journal-title":"Aliment Pharmacol Ther"},{"issue":"9","key":"448_CR24","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1046\/j.1365-2036.2003.01771.x","volume":"18","author":"PO Katz","year":"2003","unstructured":"Katz PO, Castell DO, Levine D. Esomeprazole resolves chronic heartburn in patients without erosive oesophagitis. Aliment Pharmacol Ther. 2003;18(9):875\u201382.","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"448_CR25","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1111\/j.1365-2036.2004.02155.x","volume":"20","author":"HH Tsai","year":"2004","unstructured":"Tsai HH, Chapman R, Shepherd A, McKeith D, Anderson M, Vearer D, et al. Esomeprazole 20\u00a0mg on-demand is more acceptable to patients than continuous lansoprazole 15\u00a0mg in the long-term maintenance of endoscopy-negative gastro-oesophageal reflux patients: the COMMAND study. Aliment Pharmacol Ther. 2004;20(6):657\u201365.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"448_CR26","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1365-2036.2005.02558.x","volume":"22","author":"F Pace","year":"2005","unstructured":"Pace F, Negrini C, Wiklund I, Rossi C, Savarino V. Quality of life in acute and maintenance treatment of non-erosive and mild erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther. 2005;22(4):349\u201356.","journal-title":"Aliment Pharmacol Ther"},{"issue":"4","key":"448_CR27","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.curtheres.2005.08.012","volume":"66","author":"W Janssen","year":"2005","unstructured":"Janssen W, Meier E, Gatz G, Pfaffenberger B. Effects of pantoprazole 20\u00a0mg in mild gastroesophageal reflux disease: once-daily treatment in the acute phase, and comparison of on-demand versus continuous treatment in the long term. Curr Ther Res Clin Exp. 2005;66(4):345\u201363.","journal-title":"Curr Ther Res Clin Exp"},{"issue":"6","key":"448_CR28","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1111\/j.1368-5031.2005.00564.x","volume":"59","author":"A Norman Hansen","year":"2005","unstructured":"Norman Hansen A, Bergheim R, Fagertun H, Lund H, Moum B. A randomised prospective study comparing the effectiveness of esomeprazole treatment strategies in clinical practice for 6\u00a0months in the management of patients with symptoms of gastroesophageal reflux disease. Int J Clin Pract. 2005;59(6):665\u201371.","journal-title":"Int J Clin Pract"},{"issue":"7","key":"448_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1111\/j.1365-2036.2005.02413.x","volume":"21","author":"B Bour","year":"2005","unstructured":"Bour B, Staub JL, Chousterman M, Labayle D, Nalet B, Nouel O, et al. Long-term treatment of gastro-oesophageal reflux disease patients with frequent symptomatic relapses using rabeprazole: on-demand treatment compared with continuous treatment. Aliment Pharmacol Ther. 2005;21(7):805\u201312.","journal-title":"Aliment Pharmacol Ther"},{"issue":"3","key":"448_CR30","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1111\/j.1365-2036.2005.02553.x","volume":"22","author":"S Sj\u00f6stedt","year":"2005","unstructured":"Sj\u00f6stedt S, Befrits R, Sylvan A, Harthon C, J\u00f6rgensen L, Carling L, et al. Daily treatment with esomeprazole is superior to that taken on-demand for maintenance of healed erosive oesophagitis. Aliment Pharmacol Ther. 2005;22(3):183\u201391.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 3","key":"448_CR31","doi-asserted-by":"publisher","first-page":"S40","DOI":"10.1016\/S0002-9270(03)00014-5","volume":"98","author":"KD Bardhan","year":"2003","unstructured":"Bardhan KD. Intermittent and on-demand use of proton pump inhibitors in the management of symptomatic gastroesophageal reflux disease. Am J Gastroenterol. 2003;98 Suppl 3:S40\u20138.","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"448_CR32","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1007\/s11938-008-0005-y","volume":"11","author":"F Pace","year":"2008","unstructured":"Pace F, Porro GB. On-demand PPI therapy in GERD. Curr Treat Options Gastroenterol. 2008;11(1):35\u201342.","journal-title":"Curr Treat Options Gastroenterol"},{"issue":"2","key":"448_CR33","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1111\/j.1365-2036.2007.03381.x","volume":"26","author":"F Pace","year":"2007","unstructured":"Pace F, Tonini M, Pallotta S, Molteni P, Porro GB. Systematic review: maintenance treatment of gastro-oesophageal reflux disease with proton pump inhibitors taken \u2018on-demand\u2019. Aliment Pharmacol Ther. 2007;26(2):195\u2013204.","journal-title":"Aliment Pharmacol Ther"},{"issue":"443","key":"448_CR34","first-page":"451","volume":"49","author":"AP Hungin","year":"1999","unstructured":"Hungin AP, Rubin GP, O\u2019Flanagan H. Long-term prescribing of proton pump inhibitors in general practice. Br J Gen Pract. 1999;49(443):451\u20133.","journal-title":"Br J Gen Pract"},{"issue":"4","key":"448_CR35","doi-asserted-by":"publisher","first-page":"409","DOI":"10.3109\/00365521.2013.878380","volume":"49","author":"A Nagahara","year":"2014","unstructured":"Nagahara A, Hojo M, Asaoka D, Sasaki H, Watanabe S. A randomized prospective study comparing the efficacy of on-demand therapy versus continuous therapy for 6\u00a0months for long-term maintenance with omeprazole 20\u00a0mg in patients with gastroesophageal reflux disease in Japan. Scand J Gastroenterol. 2014;49(4):409\u201317.","journal-title":"Scand J Gastroenterol"},{"issue":"6","key":"448_CR36","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1111\/j.1368-5031.2005.00563.x","volume":"59","author":"AN Hansen","year":"2005","unstructured":"Hansen AN, Wahlqvist P, J\u00f8rgensen E, Bergheim R, Fagertun H, Lund H, et al. Six-month management of patients following treatment for gastroesophageal reflux disease symptoms -- a Norwegian randomized, prospective study comparing the costs and effectiveness of esomeprazole and ranitidine treatment strategies in a general medical practitioners setting. Int J Clin Pract. 2005;59(6):655\u201364.","journal-title":"Int J Clin Pract"},{"issue":"4","key":"448_CR37","doi-asserted-by":"publisher","first-page":"267","DOI":"10.2165\/00019053-200220040-00005","volume":"20","author":"P Wahlqvist","year":"2002","unstructured":"Wahlqvist P, Junghard O, Higgins A, Green J. Cost effectiveness of proton pump inhibitors in gastro-oesophageal reflux disease without oesophagitis: comparison of on-demand esomeprazole with conventional omeprazole strategies. Pharmacoeconomics. 2002;20(4):267\u201377.","journal-title":"Pharmacoeconomics"},{"issue":"28","key":"448_CR38","doi-asserted-by":"publisher","first-page":"4291","DOI":"10.3748\/wjg.v11.i28.4291","volume":"11","author":"J Labenz","year":"2005","unstructured":"Labenz J, Malfertheiner P. Treatment of uncomplicated reflux disease. World J Gastroenterol. 2005;11(28):4291\u20139.","journal-title":"World J Gastroenterol"},{"issue":"11","key":"448_CR39","doi-asserted-by":"publisher","first-page":"2457","DOI":"10.1111\/j.1572-0241.2006.00829.x","volume":"101","author":"J Labenz","year":"2006","unstructured":"Labenz J, Nocon M, Lind T, Leodolter A, Jaspersen D, Meyer-Sabellek W, et al. Prospective follow-up data from the ProGERD study suggest that GERD is not a categorial disease. Am J Gastroenterol. 2006;101(11):2457\u201362.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"448_CR40","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1111\/j.1572-0241.2005.40476.x","volume":"100","author":"C Calabrese","year":"2005","unstructured":"Calabrese C, Bortolotti M, Fabbri A, Areni A, Cenacchi G, Scialpi C, et al. Reversibility of GERD ultrastructural alterations and relief of symptoms after omeprazole treatment. Am J Gastroenterol. 2005;100(3):537\u201342.","journal-title":"Am J Gastroenterol"},{"issue":"11","key":"448_CR41","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1080\/00365520152584725","volume":"36","author":"M Vieth","year":"2001","unstructured":"Vieth M, Haringsma J, Delarive J, Wiesel PH, Tam W, Dent J, et al. Red streaks in the oesophagus in patients with reflux disease: is there a histomorphological correlate? Scand J Gastroenterol. 2001;36(11):1123\u20137.","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"448_CR42","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1159\/000080319","volume":"22","author":"M Vieth","year":"2004","unstructured":"Vieth M, Peitz U, Labenz J, Kulig M, Naucl\u00e9r E, Jaspersen D, et al. What parameters are relevant for the histological diagnosis of gastroesophageal reflux disease without Barrett\u2019s mucosa? Dig Dis. 2004;22(2):196\u2013201.","journal-title":"Dig Dis"},{"issue":"Suppl 2","key":"448_CR43","first-page":"A382","volume":"128","author":"D Antos","year":"2005","unstructured":"Antos D, Bayerd\u00f6rffer E, B\u00e4stlein E. New evaluation of endoscopic criteria in NERD patients. Gastroenterology. 2005;128 Suppl 2:A382.","journal-title":"Gastroenterology"},{"issue":"1","key":"448_CR44","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/0895-4356(94)90036-1","volume":"47","author":"EF Juniper","year":"1994","unstructured":"Juniper EF, Guyatt GH, Willan A, Griffith LE. Determining a minimal important change in a disease-specific quality of life questionnaire. J Clin Epidemiol. 1994;47(1):81\u20137.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"448_CR45","first-page":"235","volume":"49","author":"PH Katelaris","year":"2003","unstructured":"Katelaris PH. Gastro-oesophageal reflux disease and Helicobacter pylori. Minerva Gastroenterol Dietol. 2003;49(4):235\u201341.","journal-title":"Minerva Gastroenterol Dietol"},{"issue":"Suppl 1","key":"448_CR46","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1046\/j.1365-2036.2001.00103.x","volume":"15","author":"J Dent","year":"2001","unstructured":"Dent J. Review article: is Helicobacter pylori relevant in the management of reflux disease? Aliment Pharmacol Ther. 2001;15 Suppl 1:16\u201321.","journal-title":"Aliment Pharmacol Ther"},{"issue":"Suppl 1","key":"448_CR47","doi-asserted-by":"publisher","first-page":"i13","DOI":"10.1136\/gut.2004.041533","volume":"54","author":"P Malfertheiner","year":"2005","unstructured":"Malfertheiner P, Peitz U. The interplay between Helicobacter pylori, gastro-oesophageal reflux disease, and intestinal metaplasia. Gut. 2005;54 Suppl 1:i13\u201320.","journal-title":"Gut"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12876-016-0448-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0448-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-016-0448-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T20:32:12Z","timestamp":1655497932000},"score":1,"resource":{"primary":{"URL":"http:\/\/bmcgastroenterol.biomedcentral.com\/articles\/10.1186\/s12876-016-0448-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4,14]]},"references-count":47,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["448"],"URL":"https:\/\/doi.org\/10.1186\/s12876-016-0448-x","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,4,14]]},"article-number":"48"}}